Complications and Adverse Events of Plaque Brachytherapy for Ocular Melanoma

Overview

Journal J Contemp Brachytherapy

Date 2019 Sep 17

PMID 31523242

Citations 11

Authors

Krishi V Peddada

Roshun Sangani

Hari Menon

Vivek Verma

Affiliations

Soon will be listed here.

Abstract

Plaque brachytherapy is a well-accepted modality to manage selected cases of ocular melanoma. Although this modality provides validated oncologic and quality of life benefits, severe complications and adverse events can occur. This article reviews complications and adverse events of plaque brachytherapy, including scleral necrosis, strabismus, cataract, glaucoma, and retinopathies as well as management of these conditions. For practicing oncologists and ophthalmologists, these complications are important to understand, identify, and treat. Additionally, an understanding of common complications of brachytherapy should influence the decision of pursuing it as a treatment option.

Citing Articles

Cataract Extraction After Brachytherapy for Malignant Melanoma of the Choroid in a Young Female Patient: A Case Report.

Sadhar B, Sharma P, Shakoor T, Singh S, Buzas C Cureus. 2025; 17(1):e78253.

PMID: 40026966 PMC: 11871966. DOI: 10.7759/cureus.78253.

Plaque Radiotherapy for Ocular Melanoma.

Thomas G, Chou I, Gopal L Cancers (Basel). 2024; 16(19).

PMID: 39410006 PMC: 11475076. DOI: 10.3390/cancers16193386.

Current and Emerging Radiotherapy Options for Uveal Melanoma.

Semeniuk O, Yu E, Rivard M Cancers (Basel). 2024; 16(5).

PMID: 38473430 PMC: 10931396. DOI: 10.3390/cancers16051074.

Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options.

Mularska W, Chichel A, Rospond-Kubiak I J Contemp Brachytherapy. 2023; 15(5):372-382.

PMID: 38026080 PMC: 10669920. DOI: 10.5114/jcb.2023.132398.

Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery.

Wu K, Fujioka J, Gholamian T, Zaharia M, Tran S Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765048 PMC: 10535603. DOI: 10.3390/ph16091241.

References

Gunduz K, Shields C, Shields J, Cater J, Freire J, BRADY L . Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol. 1999; 117(5):609-14. DOI: 10.1001/archopht.117.5.609. View

Wachtlin J, Bechrakis N, Schueler A, Helbig H, Bornfeld N, Foerster M . Phacoemulsification following treatment of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2001; 238(12):942-8. DOI: 10.1007/s004170000208. View

Jones I, REESE A . Focal scleral necrosis; a late sequel of irradiation. AMA Arch Ophthalmol. 1953; 49(6):633-6. DOI: 10.1001/archopht.1953.00920020646003. View

Sener E, Kiratli H, Gedik S, Sanac A . Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma. J AAPOS. 2004; 8(1):38-45. DOI: 10.1016/j.jaapos.2003.09.007. View

Hawkins B . The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2005; 138(6):936-51. DOI: 10.1016/j.ajo.2004.07.006. View

Mills M, Harbour J . Lipid exudation following plaque radiotherapy for posterior uveal melanoma. Am J Ophthalmol. 2006; 141(3):594-595. DOI: 10.1016/j.ajo.2005.10.015. View

. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006; 124(12):1684-93. DOI: 10.1001/archopht.124.12.1684. View

. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27. Ophthalmology. 2007; 114(7):1363-71. DOI: 10.1016/j.ophtha.2006.10.039. View

Dawson E, Sagoo M, Mehta J, Comer R, Hungerford J, Lee J . Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy. J AAPOS. 2007; 11(6):584-8. DOI: 10.1016/j.jaapos.2007.04.005. View

10.

Chaudhry I, Liu M, Shamsi F, Arat Y, Shetlar D, Boniuk M . Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma. Retina. 2008; 29(1):73-9. DOI: 10.1097/IAE.0b013e3181863f7c. View

11.

Radin P, Lumbroso-Le Rouic L, Levy-Gabriel C, Dendale R, Sastre X, Desjardins L . Scleral necrosis after radiation therapy for uveal melanomas: report of 23 cases. Graefes Arch Clin Exp Ophthalmol. 2008; 246(12):1731-6. DOI: 10.1007/s00417-008-0920-6. View

12.

Pilotto E, Vujosevic S, de Belvis V, Parrozzani R, Boccassini B, Midena E . Long-term choroidal vascular changes after iodine brachytherapy versus transpupillary thermotherapy for choroidal melanoma. Eur J Ophthalmol. 2009; 19(4):646-53. DOI: 10.1177/112067210901900420. View

13.

Gibran S, Kapoor K . Management of exudative retinal detachment in choroidal melanoma. Clin Exp Ophthalmol. 2009; 37(7):654-9. DOI: 10.1111/j.1442-9071.2009.02127.x. View

14.

Bianciotto C, Shields C, Pirondini C, Mashayekhi A, Furuta M, Shields J . Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology. 2010; 117(5):1005-12. DOI: 10.1016/j.ophtha.2009.10.015. View

15.

Finger P, Chin K, Yu G, Patel N . Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 80(3):800-6. DOI: 10.1016/j.ijrobp.2010.02.051. View

16.

Krema H, Xu W, Payne D, Vasquez L, Pavlin C, Simpson R . Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma. Can J Ophthalmol. 2011; 46(2):158-63. DOI: 10.3129/i10-111. View

17.

Bianciotto C, Shields C, Pirondini C, Mashayekhi A, Furuta M, Shields J . Vitreous hemorrhage after plaque radiotherapy for uveal melanoma. Retina. 2012; 32(6):1156-64. DOI: 10.1097/IAE.0b013e3182340cc1. View

18.

Piirtola A, Puska P, Kivela T . Red laser cyclophotocoagulation in the treatment of secondary glaucoma in eyes with uveal melanoma. J Glaucoma. 2012; 23(1):50-5. DOI: 10.1097/IJG.0b013e31825c0fb7. View

19.

Parrozzani R, Pilotto E, Dario A, Miglionico G, Midena E . Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma. Am J Ophthalmol. 2012; 155(1):127-133.e2. DOI: 10.1016/j.ajo.2012.06.026. View

20.

Bansal A, Bianciotto C, Maguire J, Regillo C, Shields J, Shields C . Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma. Arch Ophthalmol. 2012; 130(10):1285-90. DOI: 10.1001/archophthalmol.2012.2391. View